Author:
Yamaguchi Ryuji,Harada Hiroshi,Hirota Kiichi
Funder
Japan Society for the Promotion of Science
MEXIT
PRESTO
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Yamaguchi R, Perkins G. Challenges in targeting cancer metabolism for cancer therapy. EMBO Rep. 2012;13(12):1034–5.
2. Yamaguchi R, Perkins G. Finding a panacea among combination cancer therapies. Cancer Res. 2012;72(1):18–23.
3. Yamaguchi R, Janssen E, Perkins G, Ellisman M, Kitada S, Reed JC. Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy. PLoS One. 2011;6(9):e24102.
4. Woodward GE, Hudson MT. The effect of 2-desoxy-D-glucose on glycolysis and respiration of tumor and normal tissues. Cancer Res. 1954;14(8):599–605.
5. Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, Johnson EF, Marsh KC, Mitten MJ, Nimmer P, et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 2008;68(9):3421–8.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献